OTCM
MGROF
Market cap15mUSD
Jul 09, Last price
0.27USD
1D
9.85%
1Q
-36.30%
IPO
17.39%
Name
MUSTGROW BIOLOGICS CORP.
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MustGrow Biologics Corp., an agricultural biotechnology company headquartered in Saskatoon, Canada, since its incorporation in 2014 (and known as Duport Capital Ltd. until March 2018), specializes in developing and commercializing natural pest and weed control solutions derived from mustard seed. The company provides preplant soil biofumigation technology designed to manage soil-borne diseases and pests across various crops, including fruits and vegetables. Furthermore, MustGrow is actively developing bioherbicides to control undesirable plant growth, targeting applications in organic and conventional agriculture, as well as the home and garden sectors. Its work also extends to postharvest food preservation, focusing on treatments to prevent sprouting, disease, and pathogens during storage. Among its key innovations is CannaPM, an active ingredient being developed to address both fungal soil diseases and foliar diseases.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||